Pliant Therapeutics Inc (PLRX) support and resistance · $77.3M cap
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
This page maps Pliant Therapeutics Inc (PLRX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
PLRX currently screens at market cap $77.3M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PLRX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PLRX quote page for the session range and the stock page for the full model.
Not investment advice.